Status:
COMPLETED
Adult Oral Ibuprofen Study for ED Pain Patients
Lead Sponsor:
Antonios Likourezos
Conditions:
Pain, Acute
Eligibility:
All Genders
18-120 years
Phase:
PHASE4
Brief Summary
Ibuprofen is one of the most widely used non-steroidal anti-inflammatory drug (NSAID) for management of mild -to moderate pain in the ED (acute musculo-skeletal pain, headache, dental pain). Ibuprofen...
Detailed Description
STUDY DESIGN A randomized, double-blind trial to determine the analgesic equivalency of orally administered ibuprofen at 400 mg for the treatment of acute pain in comparison to with higher doses of 60...
Eligibility Criteria
Inclusion
- Adult ED patients aged 18 and older
- Chief complaint of mild to moderate musculoskeletal pain, headache, or dental pain intensity of less than 4 on a standard 0 to 10 numeric rating scale.
- Acute pain (within 30 days of onset)
- Patients who would routinely be treated with oral ibuprofen
Exclusion
- pregnancy or breastfeeding,
- active peptic ulcer disease,
- acute gastrointestinal hemorrhage,
- known history of severe renal or hepatic insufficiency, allergy to nonsteroidal anti-inflammatory drugs,
- patients having already received analgesic medication.
Key Trial Info
Start Date :
November 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2019
Estimated Enrollment :
225 Patients enrolled
Trial Details
Trial ID
NCT03441269
Start Date
November 1 2018
End Date
August 31 2019
Last Update
June 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maimonides Medical Center
Brooklyn, New York, United States, 11219